What have we been up to in Q3?

As we wrap up another busy and successful quarter, we're excited to share some progress and milestones we've achieved over the last few months.

Study Announcements

Cleo Diagnostics

In early September, it was announced that Cleo Diagnostics' trial, evaluating a blood test for ovarian cancer screening, enrolled its first patients. Read their announcement. 

Pila Pharma

This Phase 2a dose-escalation trial will assess the safety and tolerability of XEN-D0501, a TRPV-1 antagonist, in obese patients with type 2 diabetes. Read the full press release.

Aptar Digital Health

This study aims to show improvements in asthma control symptoms, medication adherence, and more through Aptar's Respiratory Disease Management Portal (DMP). Read the full announcement.

Our first live webinar with Habitual

In August, we hosted our very first live webinar with Habitual discussing best practices for consumer health trial execution relating to study design and recruitment and retention strategies. We also talked about specific methods we deployed for our study together, DIGEST, to assess diabetes remission and weight loss with Habitual's diet replacement + digital remission program.

Watch the full episode on our Youtube channel, or get the case study.

Events

We attended five conferences last quarter, including the 16th Annual Next Generation Dx Summit, where Lindus co-founder Meri Beckwith presented on strategies for executing clinical trials for infectious disease diagnostics with Valentina Milanova, founder of Daye .

In addition, co-founder Michael Young gave a presentation at the Society for Clinical Research Associates' (SOCRA) 2024 Annual Conference, highlighting strategies to promote diversity in clinical trials based on findings from our research with the University of Oxford.

New Content

WHITE PAPER: Diverse Trials, Better Treatments

Discover strategies to boost diversity in clinical trials based on our research with the University of Oxford . Get the full white paper.

GUIDE: Enhancing Participant Recruitment & Retention in Ophthalmology Clinical Trials

Maximize recruitment and keep patients engaged in your ophthalmology trials with strategies from our guide.

We can't wait to share more updates with you as we wrap up the rest of this year. We appreciate you following along and being part of our community!